{"acute myeloid leukaemia": 2.12, "adenocarcinoma of colon": 24.18, "age-related macular degeneration": 22.11, "anaemia": 3.15, "aphonia": 4.43, "ascites": 4.13, "bacteraemia": 3.96, "blindness": 4.43, "blindness transient": 3.62, "blood albumin decreased": 3.93, "blood pressure diastolic increased": 10.17, "body temperature decreased": 3.87, "bone marrow disorder": 10.01, "bone marrow failure": 2.47, "breast cancer metastatic": 2.71, "candida infection": 2.41, "carcinoembryonic antigen increased": 12.86, "cardiotoxicity": 6.92, "colon cancer": 2.84, "colon cancer metastatic": 38.83, "colorectal cancer metastatic": 98.33, "dehydration": 2.1, "dermatitis acneiform": 4.63, "diabetic foot": 11.13, "diabetic retinal oedema": 76.91, "diabetic retinopathy": 7.86, "diarrhoea": 2.59, "disease progression": 15.18, "disseminated intravascular coagulation": 2.9, "drug resistance": 3.55, "dry throat": 5.03, "eastern cooperative oncology group performance status worsened": 21.77, "ejection fraction decreased": 3.16, "embolism": 4.62, "enteritis": 6.12, "epistaxis": 4.22, "eye discharge": 27.69, "eye disorder": 2.42, "eye haemorrhage": 8.68, "eye irritation": 3.11, "eye pruritus": 7.53, "febrile neutropenia": 7.4, "fournier's gangrene": 4.39, "gastrointestinal disorder": 2.93, "gastrointestinal perforation": 17.87, "gastrointestinal toxicity": 25.66, "gene mutation": 10.09, "granulocyte count decreased": 10.6, "haematocrit decreased": 2.56, "haematotoxicity": 22.53, "haemoglobin decreased": 2.38, "haemorrhage": 3.34, "hepatic function abnormal": 2.5, "hepatic steatosis": 2.78, "hepatitis b reactivation": 7.75, "hiccups": 8.38, "hyperbilirubinaemia": 2.85, "hypertension": 4.77, "hypokalaemia": 3.3, "hypomagnesaemia": 6.53, "ileus": 7.38, "incoherent": 6.48, "increased insulin requirement": 36.57, "intestinal obstruction": 3.82, "intestinal perforation": 11.79, "large intestine perforation": 23.1, "left ventricular dysfunction": 8.88, "leukopenia": 5.97, "liver injury": 2.11, "lymphocyte count decreased": 3.0, "macular oedema": 34.43, "magnetic resonance imaging head abnormal": 19.81, "malignant neoplasm progression": 5.64, "mental status changes": 2.41, "metastases to bone": 5.19, "metastases to central nervous system": 5.07, "metastases to liver": 14.05, "metastases to lung": 14.38, "metastases to lymph nodes": 9.72, "metastases to peritoneum": 17.59, "metastases to pleura": 19.81, "mucosal inflammation": 8.48, "myelodysplastic syndrome": 2.68, "myelosuppression": 25.75, "neoplasm progression": 9.58, "nephrotic syndrome": 5.6, "nerve injury": 2.27, "neuropathy peripheral": 11.49, "neurotoxicity": 17.47, "neutropenia": 9.48, "neutrophil count decreased": 13.28, "non-small cell lung cancer": 4.78, "ocular discomfort": 2.22, "osteonecrosis of jaw": 3.62, "ovarian cancer": 10.21, "palmar-plantar erythrodysaesthesia syndrome": 7.09, "pancytopenia": 2.09, "paronychia": 7.47, "performance status decreased": 2.22, "peripheral sensory neuropathy": 9.3, "peritonitis": 5.22, "pharyngeal oedema": 4.62, "photopsia": 2.65, "platelet count decreased": 4.63, "pneumocystis jirovecii pneumonia": 2.77, "pneumonitis": 2.07, "polyneuropathy": 2.36, "poor peripheral circulation": 9.46, "portal hypertension": 8.8, "portal vein thrombosis": 5.87, "posterior reversible encephalopathy syndrome": 14.74, "product use in unapproved indication": 2.73, "product use issue": 3.74, "protein urine present": 5.51, "proteinuria": 15.08, "pulmonary toxicity": 5.41, "rectal haemorrhage": 2.32, "red blood cell count decreased": 2.33, "scleral thinning": 419.07, "second primary malignancy": 2.5, "skin toxicity": 12.81, "small intestinal obstruction": 6.03, "small intestinal perforation": 13.4, "splenomegaly": 2.1, "stomatitis": 3.71, "subretinal fluid": 17.28, "suture rupture": 98.86, "therapeutic product effect incomplete": 2.61, "therapeutic response decreased": 2.05, "therapy partial responder": 11.11, "thrombocytopenia": 4.98, "thrombotic microangiopathy": 5.59, "toxicity to various agents": 4.45, "treatment failure": 2.64, "tumour lysis syndrome": 2.69, "tumour necrosis": 76.01, "visual acuity reduced": 2.85, "vitreous floaters": 2.78, "vitreous haemorrhage": 10.39, "white blood cell count decreased": 8.81, "wound dehiscence": 44.99, "wound infection": 7.08}